Difficulty: Medium
Average Score: 75%
Practice
All of the following statements regarding cardiac glycoside-induced ventricular tachyarrhythmias are true EXCEPT:
Correct answer
C
Rationale
Rationale:
C is the correct answer because cardiac glycoside-induced ventricular tachyarrhythmias are more common in patients with hypokalemia, not hyperkalemia. This is due to the increased sensitivity of the myocardium to glycosides in the setting of low potassium levels. A: Lidocaine is not the drug of choice for treating these arrhythmias; instead, antiarrhythmic medications like phenytoin or amiodarone are preferred. B: Digibind (Digoxin-specific antibody) is used in severe cases to reverse the effects of cardiac glycosides. D: Patients with heart failure or preexisting heart damage are at higher risk for developing these arrhythmias due to impaired cardiac function and increased susceptibility to glycoside toxicity.
C is the correct answer because cardiac glycoside-induced ventricular tachyarrhythmias are more common in patients with hypokalemia, not hyperkalemia. This is due to the increased sensitivity of the myocardium to glycosides in the setting of low potassium levels. A: Lidocaine is not the drug of choice for treating these arrhythmias; instead, antiarrhythmic medications like phenytoin or amiodarone are preferred. B: Digibind (Digoxin-specific antibody) is used in severe cases to reverse the effects of cardiac glycosides. D: Patients with heart failure or preexisting heart damage are at higher risk for developing these arrhythmias due to impaired cardiac function and increased susceptibility to glycoside toxicity.